Cytomegalovirus Treatment Market: Improvement in Efficacy of Combinational Antiviral Therapy and Growing Awareness Regarding Cytomegalovirus Infections Expected to Enhance Revenue Growth: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
- Healthcare, Pharmaceuticals and Medical devices
- No. of Pages: 221
- Published: 2019-01-28
- Report Code: REP-GB-8665
-
Format:
An Incisive, In-depth Analysis on the Cytomegalovirus Treatment Market
This study offers a comprehensive, 360 degree analysis on the Cytomegalovirus Treatment market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Cytomegalovirus Treatment market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Combinational Antiviral Therapy Will Create More Opportunities for Cytomegalovirus Treatment
The most important and effective strategy in the prevention of cytomegalovirus infection is to avoid immunodeficiency as it increases the risk of infection and cytomegalovirus reactivation. The wide use of combinational antiviral therapy is decreasing the rate of HIV infection in people. Antiviral agents coupled with the use of cART affects immune restoration and will give a push to the cytomegalovirus treatment market worldwide.
Growing Prevalence of Congenital CMV Infection
Congenital Cytomegalovirus disease transpires in approximately 1% of all live births. The bulk of the cases are asymptomatic, but almost 5–10% of infants with congenital CMV will have significant chances of disease. CMV infection in the neonate generates attenuated interferon response associated to a similar infection in the adult. Cytomegalovirus infection and risk of reactivation of cytomegalovirus infection have been reported during pregnancy. These can also lead to congenital CMV infection. Prediction for neonates with infection is poor, with a high possibility of mental deficits, hearing loss, prematurity, hepatosplenomegaly, jaundice. Morbidity & mortality are connected with congenital CMV infection, emphasizing the requirement for cytomegalovirus treatment and vaccine to inhibit CMV infection. Antiviral agents such as ganciclovir, valganciclovir reduce the risk hearing disorders. Ganciclovir and valganciclovir provide advances in cytomegalovirus treatment because of oral bioavailability, efficacy, and limitation of toxicity. There is a need for new drugs, as comparatively few research programs are currently focusing on anti-cytomegalovirus treatment.
CMV Retinitis among AIDS Patients to Drive Cytomegalovirus Treatment Market Growth
The cytomegalovirus treatment market is expected to witness lucrative growth due to increasing cases of CMV retinitis. Cytomegalovirus retinitis is a moderately rare exhibition of cytomegalovirus disease in other immunocompromised populations. It is the initial indication of cytomegalovirus infection in patients with AIDS. Up to 25% of patients with AIDS developed cytomegalovirus retinitis. Cytomegalovirus retinitis is a disease identified by necrotizing retinitis that can begin to cause retinal organization and blindness. Cytomegalovirus retinitis and other exhibitions of cytomegalovirus disease in individuals with HIV-1 infection are opportunistic infections, transpiring when CD4+ cell counts are extremely suppressed. High value-added active antiretroviral therapy will drive the growth of the cytomegalovirus treatment market. The growing demand for cytomegalovirus treatment, due to the increasing prevalence of cytomegalovirus retinitis in AIDS patients is the major factor fueling the cytomegalovirus treatment market across the globe.
Growing Awareness of Cytomegalovirus Treatment in Stem Cell Transplant
The rising prevalence and incidences of cytomegalovirus infections is a prime driver of the cytomegalovirus treatment market. The cytomegalovirus treatment market is mainly growing because of the rising prevalence rate of cytomegalovirus infection in different indications such as congenital CMV, cytomegalovirus retinitis, stem cell transplant. The growing awareness of herpes is also driving the cytomegalovirus treatment market. Increased educational programs about cytomegalovirus infection and cytomegalovirus treatment, by public health interventions and pediatric counseling, are needed for all pregnant women to prevent cytomegalovirus infections.
Competitive Landscape
The competition section of the report features profiles of key players operating in the cytomegalovirus treatment market based on their market shares, differential strategies, product offerings, marketing approach, and company dashboard. Examples of some of the key players featured in this report include Merck & Co. Inc, Mylan N.V., Chimerix, Inc., Thermo Fisher Scientific, Abbott, Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pfizer, and among others.
Mergers and acquisitions, product innovations, and partnerships are the some of the key strategies being adopted by the manufactures of to gain maximum share in the cytomegalovirus treatment market. Manufacturers are also planning to invest in new facilities to increase productivity.
Definition
Cytomegalovirus is a common virus of the herpes family which also includes the herpes simplex viruses and causes chickenpox and mononucleosis. Cytomegalovirus infects people of all ages and CMV is spread through body fluids such as blood, saliva, tears, breast milk, urine, semen, and vaginal fluids. Antiviral drug and combinational of antiviral therapy are used to treat cytomegalovirus infections.
About the Report
The company has conducted a research study on the cytomegalovirus treatment market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the cytomegalovirus treatment market. The report elaborates the macroeconomic factors influencing the dynamics in the cytomegalovirus treatment market and its futuristic potential.
Segmentation
The report offers a comprehensive taxonomy of the cytomegalovirus treatment market based on drug type, application, and distribution channel. Based on drug type, the cytomegalovirus treatment market is segmented into ganciclovir, valganciclovir, foscarnet, cidofovir, and other. Based on application, the cytomegalovirus treatment market is segmented into stem cell transplantation, organ transplantation, congenital CMV infection, and others. Based on distribution channel, the cytomegalovirus treatment market is segmented into hospital pharmacies, retail pharmacies, and e-commerce. The cytomegalovirus treatment market has been analyzed across regions of North America, Latin America, Western Europe, Eastern Europe and Asia Pacific Including Japan, China and MEA.
Additional Questions Answered
Some of the additional questions addressed in this report on the cytomegalovirus treatment market-
-
What is the revenue potential of the cytomegalovirus treatment market across regions of North America and Europe?
-
Who are the key competitors and what are their portfolios in the cytomegalovirus treatment market?
-
What are some of the major challenges influencing the growth of the cytomegalovirus treatment market?
-
How intervention from the regulatory authorities is shaping the cytomegalovirus treatment market growth?
Research Methodology
The cytomegalovirus treatment market has been estimated based on supply-demand approach. All the information has been further validated through rigorous primary research (including interviews, surveys, in-person interactions and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals and resourceful databases). The research study on the cytomegalovirus treatment market also includes top trends and macro as well as micro economic factors shaping the cytomegalovirus treatment market.
A recent market study published by the company – 'Cytomegalovirus Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028', consists of an inclusive assessment of the most important market dynamics on Cytomegalovirus with assessed medications. The company has done some direct research on the principle structure of the Cytomegalovirus treatment market. A direct market overview provides the growth scenarios and market potential with maximum precision, and adjudged with suitable assumptions. The report features unique and relevant factors that may have a huge impact on the development of the Cytomegalovirus treatment market during the forecast period. This report includes a detailed and considerable amount of inclusion, which would help new manufacturers with the most comprehensive way for better understanding
Chapter 1 – Executive Summary
The report commences with the executive summary of the Cytomegalovirus treatment market report, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) for leading segments in the Cytomegalovirus treatment market.
Chapter 2 – Market Introduction
Readers can find a detailed market structure and definition of Cytomegalovirus treatment and drug types, in this chapter, which helps in understanding the basic information about the Cytomegalovirus treatment market. The definition section considers the factors included and excluded for the purpose of this report.
Chapter 3 – Market Background
Readers can find the outlook of the global Cytomegalovirus treatment market, considering various factors associated with the growth, which would help in tracking the market’s current scenario, with key inferences drawn from historical data, current trends, and future prospects. Macro-economic factors influencing the market are also discussed in this segment. A brief understanding of the global healthcare sector is also provided in this section.
Chapter 4 – Market Dynamics
This chapter highlights the key market dynamics, including drivers, restraints, opportunities, and trends. In this chapter, readers can understand factors that are propelling the growth of the market, along with factors that may deter the growth of the market. Also, readers will understand the key trends followed by leading manufacturers in the Cytomegalovirus treatment market.
Chapter 5 – Cytomegalovirus Treatment Market: Key Inclusions
Key pointers such as pipeline drug analysis, reimbursement scenarios and new medical treatments for Cytomegalovirus are also included in this Cytomegalovirus treatment market report.
Chapter 6 – North America Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028
This chapter includes detailed analysis of the growth being observed in the North America Cytomegalovirus treatment market, along with country-wise assessment for the U.S. and Canada. Readers can also find information on regional trends, regulations and market growth based on Drug type, Application and Distribution channel and countries in North America.
Chapter 7 – Western Europe Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028
Important growth prospects of the Cytomegalovirus treatment market can be found with market attractiveness based on Drug type, Application and Distribution channel. European countries such as the U.K., Germany, France, Italy, Spain, Russia and Rest of Western Europe are included in this chapter for industry analysis.
Chapter 8 – Eastern Europe Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028
This chapter includes detailed analysis of the growth of the Eastern Europe Cytomegalovirus treatment market, along with a country-wise assessment, including Russia, Poland and Rest of Eastern Europe. Market attractiveness based on various segments is provided for the Eastern European region.
Chapter 9 – Latin America Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028
This chapter includes detailed analysis of the growth of the Latin America Cytomegalovirus treatment market, along with a country-wise assessment, including Brazil, Mexico and Rest of Latin America. Market attractiveness based on various segments is provided for the Latin American region
Chapter 10 – APEC Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028
India, Australia & New Zealand, Japan and Rest of APAC are the leading countries/regions in the Asia Pacific region that are assessed to obtain the growth prospects of the APEC Cytomegalovirus treatment market in this chapter. Readers can find thorough information about the growth parameters. Market attractiveness based drug type, Application, and distribution channel for Cytomegalovirus treatment in the APEC region is also provided in this section.
Chapter 11 – China Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028
This chapter includes detailed analysis of the growth of the China Cytomegalovirus treatment market. Market attractiveness based drug type, Application, and distribution channel is present for this region
Chapter 12 – MEA Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028
This chapter provides information on how the Cytomegalovirus treatment market will grow in major countries of the MEA region, such as Saudi Africa, GCC Countries and Rest of MEA, during the period 2018-2028.
Chapter 13 – Forecast Factors: Relevance and Impact
This chapter provides forecast factors for relevance in building the market value for the Cytomegalovirus treatment market
Chapter 14 – Competitive Assessment
This chapter includes a comprehensive list of all the leading manufacturers in the Cytomegalovirus treatment market, along with detailed information about each company, including company overview, revenue share, strategic overview, and recent company developments. Market players featured in the report include Merck & Co. Inc, Mylan N.V., Chimerix, Inc., Thermo Fisher Scientific, Abbott, Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pfizer and among others
Chapter 15 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Region
This section highlights Cytomegalovirus treatment in the overall global market by value (US$ Mn) forecast and analysis, by region such as North America, Latin America, Western Europe, Eastern Europe and Asia Pacific Including Japan, China and MEA.
Chapter 16 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Drug Type
Based on drug type market analysis, the Cytomegalovirus treatment market is segmented into Ganciclovir, valganciclovir, Foscarnet, Cidofovir and other.
Chapter 17 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Application
Based on Application, the Cytomegalovirus treatment market is segmented into Stem Cell Transplantation, Organ Transplantation, Congenital CMV infection and others.
Chapter 18 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Distribution Channel
Based on distribution channel, the Cytomegalovirus treatment market is segmented into hospital pharmacies, retail pharmacies, drugstores, and e-Commerce.
Chapter 19 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028
This section highlights the overall global market value (US$ Mn) forecast and analysis of the Cytomegalovirus treatment market, with detailed incremental opportunity and absolute opportunity.
Chapter 20 – Assumptions and Acronyms Used
This section consists of a glossary of the assumptions and acronyms used in the Cytomegalovirus treatment market report.
Chapter 21 – Research Methodology
This chapter helps readers understand the research methodology that is followed to obtain various conclusions, important qualitative information, and quantitative information about the Cytomegalovirus treatment market.
Cytomegalovirus Treatment Market Reports - Table of Contents
13. Forecast Factors: Relevance and Impact
20. Assumptions and Acronyms Used
21. Research Methodology
Cytomegalovirus Treatment Market Reports - List of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Respective codes for Cytomegalovirus Treatment
Table 04: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Country
Table 05: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Drug Type
Table 06: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Application
Table 07: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Distribution Channel
Table 08: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Country
Table 09: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Drug Type
Table 10: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Application
Table 11: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Distribution Channel
Table 12: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Country
Table 13: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Drug Type
Table 14: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Application
Table 15: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Distribution Channel
Table 16: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Country
Table 17: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Drug Type
Table 18: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Application
Table 19: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Distribution Channel
Table 20: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Country
Table 21: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Drug Type
Table 22: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Application
Table 23: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Distribution Channel
Table 24: China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Drug Type
Table 25: China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Application
Table 26: China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Distribution Channel
Table 27: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Country
Table 28: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Drug Type
Table 29: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Application
Table 30: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Distribution Channel
Table 31: Global Cytomegalovirus Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2018–2028, By Region
Table 32: Global Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Drug Type
Table 33: Global Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Application
Table 34: Global Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2017 and Opportunity Assessment 2018-2028, By Distribution Channel
Cytomegalovirus Treatment Market Reports - List of Figures
Figure 01: Global Cytomegalovirus Treatment Market Split By Drug Type (2018)
Figure 02: Global Cytomegalovirus Treatment Market Split By Application (2018)
Figure 03: Global Cytomegalovirus Treatment Market Value 2018 & 2028
Figure 04: Global Cytomegalovirus Treatment Market Split By Distribution Channel (2018)
Figure 05: Global Cytomegalovirus Treatment Market Split By Region (2018)
Figure 06: Global Overview of Clinical Trails, by Region
Figure 07: Clinical trials of cytomegalovirus treatments as reported, by Phase
Figure 08: Reported number of study type for each clinical trial
Figure 9: North America Cytomegalovirus Treatment Market Value Share, By Drug Type (2018)
Figure 10: North America Cytomegalovirus Treatment Market Value Share, By Application (2018)
Figure 11: North America Cytomegalovirus treatment market value analysis US$
Figure 12: North America Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2018)
Figure 13: North America Cytomegalovirus Treatment Market Value Share, By Country (2018)
Figure 14: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 15 : North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 16: U.S. Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 17 : U.S. Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 18: Canada Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 19 : Canada Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 20 : North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Ganciclovir
Figure 21: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Ganciclovir
Figure 22: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Valganciclovir
Figure 23: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Valganciclovir
Figure 24: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Foscarnet
Figure 25: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Foscarnet
Figure 26: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Cidofovir
Figure 27: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Cidofovir
Figure 28: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Others
Figure 29: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Others
Figure 30: North America Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type
Figure 31: North America Cytomegalovirus Treatment Market Attractiveness Analysis, By Application
Figure 32: North America Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 33: North America Cytomegalovirus Treatment Market Attractiveness Analysis, By Country
Figure 34: Latin America Cytomegalovirus Treatment Market Value Share, By Drug Type (2018)
Figure 35: Latin America Cytomegalovirus Treatment Market Value Share, By Application (2018)
Figure 36: Latin America Cytomegalovirus treatment market value analysis US$
Figure 37: Latin America Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2018)
Figure 38: Latin America Cytomegalovirus Treatment Market Value Share, By Country (2018)
Figure 39: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 40 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 41: Brazil Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 42 : Brazil Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 43: Mexico Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 44 : Mexico Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 45 : Rest Of Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 46: Rest Of Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 47 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Ganciclovir
Figure 48 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Ganciclovir
Figure 49 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Valganciclovir
Figure 50 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Valganciclovir
Figure 51 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Foscarnet
Figure 52: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Foscarnet
Figure 53: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Cidofovir
Figure 54: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Cidofovir
Figure 55: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Others
Figure 56: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Others
Figure 57: Latin America Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type
Figure 58: Latin America Cytomegalovirus Treatment Market Attractiveness Analysis, By Application
Figure 59: Latin America Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 60: Latin America Cytomegalovirus Treatment Market Attractiveness Analysis, By Country
Figure 61: Western Europe Cytomegalovirus Treatment Market Value Share, By Drug Type (2018)
Figure 62: Western Europe Cytomegalovirus Treatment Market Value Share, By Application (2018)
Figure 63: Western Europe Cytomegalovirus treatment market value analysis US$
Figure 64: Western Europe Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2018)
Figure 65: Western Europe Cytomegalovirus Treatment Market Value Share, By Country (2018)
Figure 66: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 67 : Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 68: U.K. Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 69 : U.K. Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 70 : Germany Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 71: Germany Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 72: France Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 73 : France Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 74 : Italy Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 75 : Italy Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 76: Spain Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 77: Spain Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 78: Rest of Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 79: Rest of Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 80 : Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Ganciclovir
Figure 81: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Ganciclovir
Figure 82: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Valganciclovir
Figure 83: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Valganciclovir
Figure 84: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Foscarnet
Figure 85: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Foscarnet
Figure 86: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Cidofovir
Figure 87: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Cidofovir
Figure 88: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Others
Figure 89: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Others
Figure 90: Western Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type
Figure 91: Western Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Application
Figure 92: Western Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 93: Western Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Country
Figure 94: Eastern Europe Cytomegalovirus Treatment Market Value Share, By Drug Type (2018)
Figure 95: Eastern Europe Cytomegalovirus Treatment Market Value Share, By Application (2018)
Figure 96: Eastern Europe Cytomegalovirus treatment market value analysis US$
Figure 97: Eastern Europe Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2018)
Figure 98: Eastern Europe Cytomegalovirus Treatment Market Value Share, By Country (2018)
Figure 99: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 100: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 101: Russia Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 102 : Russia Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 103 : Poland Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 104 : Poland Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 105 : Rest of Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 106: Rest of Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 107 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Ganciclovir
Figure 108 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Ganciclovir
Figure 109 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Valganciclovir
Figure 110 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Valganciclovir
Figure 111 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Foscarnet
Figure 112 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Foscarnet
Figure 113 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Cidofovir
Figure 114 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Cidofovir
Figure 115 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Others
Figure 116 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Others
Figure 117: Eastern Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type
Figure 118: Eastern Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Application
Figure 119: Eastern Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 120: Eastern Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Country
Figure 121: APEC Cytomegalovirus Treatment Market Value Share, By Drug Type (2018)
Figure 122: APEC Cytomegalovirus Treatment Market Value Share, By Application (2018)
Figure 123: APEC Cytomegalovirus treatment market value analysis US$
Figure 124: APEC Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2018)
Figure 125: APEC Cytomegalovirus Treatment Market Value Share, By Country (2018)
Figure 126: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 127 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 128: India Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 129: India Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 130 : Australia & NZ Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 131 : Australia & NZ Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 132: Japan Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 133 : Japan Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 134 : Rest of APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 135 : Rest of APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 136 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Ganciclovir
Figure 137 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Ganciclovir
Figure 138 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Valganciclovir
Figure 139 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Valganciclovir
Figure 140 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Foscarnet
Figure 141 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Foscarnet
Figure 142 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Cidofovir
Figure 143 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Cidofovir
Figure 144 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Others
Figure 145 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Others
Figure 146: APEC Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type
Figure 147: APEC Cytomegalovirus Treatment Market Attractiveness Analysis, By Application
Figure 148: APEC Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 149: APEC Cytomegalovirus Treatment Market Attractiveness Analysis, By Country
Figure 150: China Cytomegalovirus Treatment Market Value Share, By Drug Type (2018)
Figure 151: China Cytomegalovirus Treatment Market Value Share, By Application (2018)
Figure 152: China Cytomegalovirus treatment market value analysis US$
Figure 153: China Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2018)
Figure 154: China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 155: China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 156 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Ganciclovir
Figure 157 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Ganciclovir
Figure 158 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Valganciclovir
Figure 159 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Valganciclovir
Figure 160 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Foscarnet
Figure 161 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Foscarnet
Figure 162 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Cidofovir
Figure 163 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Cidofovir
Figure 164 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Others
Figure 165 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Others
Figure 166: China Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 167: China Cytomegalovirus Treatment Market Attractiveness Analysis, By Application
Figure 168: China Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type
Figure 169: MEA Cytomegalovirus Treatment Market Value Share, By Drug Type (2018)
Figure 170: MEA Cytomegalovirus Treatment Market Value Share, By Application (2018)
Figure 171: MEA Cytomegalovirus treatment market value analysis US$
Figure 172: MEA Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2018)
Figure 173: MEA Cytomegalovirus Treatment Market Value Share, By Country (2018)
Figure 174: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 175 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 176: South Africa Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 177 : South Africa Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 178 : GCC Countries Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 179 : GCC Countries Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 180 : Rest of MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 181: Rest of MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 182 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Ganciclovir
Figure 183 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Ganciclovir
Figure 184 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Valganciclovir
Figure 185 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Valganciclovir
Figure 186 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Foscarnet
Figure 187 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Foscarnet
Figure 188 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Cidofovir
Figure 189 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Cidofovir
Figure 190 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Others
Figure 191 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Others
Figure 192: MEA Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type
Figure 193: MEA Cytomegalovirus Treatment Market Attractiveness Analysis, By Application
Figure 194: MEA Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 195: MEA Cytomegalovirus Treatment Market Attractiveness Analysis, By Country
Figure 196: Global Cytomegalovirus Treatment Market Share Analysis (%), By Region, 2018 & 2028
Figure 197: Global Cytomegalovirus Treatment Market Y-o-Y Analysis (%), By Region, 2018-2028
Figure 198: Global Cytomegalovirus Treatment Market Attractiveness Analysis by Region, 2018-2028
Figure 199: Global Cytomegalovirus Treatment Market Share Analysis (%), By Drug Type, 2018 & 2028
Figure 200: Global Cytomegalovirus Treatment Market Y-o-Y Analysis (%), By Drug Type, 2018-2028
Figure 201: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Ganciclovir
Figure 202: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Ganciclovir
Figure 203: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Valganciclovir
Figure 204: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Valganciclovir
Figure 205: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Foscarnet
Figure 206: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Foscarnet
Figure 207: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Cidofovir
Figure 208: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Cidofovir
Figure 209: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Others
Figure 210: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Others
Figure 211: Global Cytomegalovirus Treatment Market Attractiveness Analysis by Drug Type, 2018-2028
Figure 212: Global Cytomegalovirus Treatment Market Share Analysis (%), By Application, 2018 & 2028
Figure 213: Global Cytomegalovirus Treatment Market Y-o-Y Analysis (%), By Application, 2018-2028
Figure 214: Global Cytomegalovirus Treatment Market Attractiveness Analysis by Application, 2018-2028
Figure 215: Global Cytomegalovirus Treatment Market Share Analysis (%), By Distribution Channel, 2018 & 2028
Figure 216: Global Cytomegalovirus Treatment Market Y-o-Y Analysis (%), By Distribution Channel, 2018-2028
Figure 217: Global Cytomegalovirus Treatment Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 218: Global Cytomegalovirus Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 219: Global Cytomegalovirus Treatment Market Size (US$ Mn) Opportunity Assessment & Y-o-Y Growth (%), 2018-2028
Figure 220: Global Cytomegalovirus Treatment Market Absolute $ Opportunity, 2018–2028
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.